INTRODUCTION
Extensive experimental data and clinical observations indicate that brain serotonin (5-hydroxytryptamine; 5-HT) plays a pivotal role in the regulation of many physiological processes and complex behaviors (23), including sleep (25; 35) , and thermoregulation (29; 30) . It is now thought that 5-HT, release of which is maximal during wakefulness, promotes wakefulness per se by actions on 5-HT 2 receptors, and subsequently triggers sleep via induction of sleeppromoting systems (25; 26) . Recent data directly support this dual role for 5-HT in the regulation of arousal state. We showed that increasing serotonergic activity at the beginning of the dark period by intraperitoneal (IP) injection of the 5-HT precursor L -5-hydroxytryptophan (5-HTP) results in dose-related and biphasic changes in sleep-wake behavior of rats; low doses initially enhance wakefulness, which is later followed by increased non-rapid eye movement (NREM) sleep (20) . Under those experimental conditions, serotonergic activation at dark onset induces hypothermia, the duration of which encompasses periods of both increased wakefulness and of enhanced NREM sleep.
The contribution of 5-HT to the regulation of arousal state and thermoregulation involves multiple systems. Brain 5-HT acts directly on neural systems implicated in the regulation of arousal state, such as neurons in the pontine tegmentum [laterodorsal (LDT) and pedunculopontine (PPT) nuclei], neurons in the ventrolateral preoptic (VLPO) and suprachiasmatic (SCN) nuclei (8; 24; 35; 40) , as well as on hypothalamic thermoregulatory neurons (29) . In addition to direct actions on neural systems that regulate arousal state and thermoregulation, the effects of 5-HT on these processes may be mediated by indirect actions on other systems. For example, serotonergic axons synapse on corticotropin-releasing hormone Rats are nocturnal and the dark period is for these animals the active phase when they are awake the most and their body temperatures are highest. Conversely, the light period is the rest phase for rats, during which they sleep the most and body temperatures are at their lowest.
Because sleep-wake behavior and thermoregulation are strongly influenced by circadian factors, the impact of serotonergic activation on arousal state and body temperature may differ depending on the timing of activation. We hypothesized that if serotonergic activation occurs at the beginning of the light period, the initial increase in wakefulness of rats would be proportionally greater than that occurring when 5-HTP is administered prior to the beginning of the dark period.
Furthermore, we hypothesized that because body temperatures of rats are lower during the light period than during the dark period, the hypothermic response to serotonergic activation at the beginning of the light period would be proportionally less than that following serotonergic activation at the beginning of the dark period. To test these hypotheses, rats were injected IP at light onset with 5-HTP and sleep-wake behavior determined and brain cortical temperature (Tcort) recorded. Finally, in an initial attempt to elucidate the mechanisms responsible for the wake-promoting effects of serotonergic activation, we hypothesized that if elevated 5-HT in brain stimulates CRH in the hypothalamus, which would induce wakefulness, then antagonizing the central actions of this peptide would reduce the extent to which wakefulness increases after wakefulness, but does alter the magnitude of the hypothermic response.
MATERIALS AND METHODS
Parallel studies were conducted in two laboratories. Experiment 1 (see later) was conducted at the University of Milan (LI, SB) to facilitate comparison with data derived from previous studies of the impact of 5-HTP on sleep-wake behavior of rats. These studies were conducted on the same strain of rats and under the same conditions previously reported (20 Insulated leads were routed from the EEG electrodes (and EMG electrodes, when used) and the thermistor to a Teflon pedestal (Plastics One Inc., Roanoke, VA, USA) that was cemented in place with dental acrylic (Isocryl; Lang Dental Supply, Wheeling, IL, USA). This pedestal was used to connect the animals to the recording apparatus via a flexible tether and electronic swivel.
The incision was treated topically with polysporin (polymyxin B sulfate -bacitracin zinc) and the animals were placed under heat lamps and monitored until recovery from anesthesia. The animals were allowed seven days recovery from the surgical procedures. On the second postsurgical day, the rats were connected to the recording apparatus (see later) via a flexible tether that allowed relatively unrestricted movement within the cage. For the next five days the animals were habituated by daily handling that coincided with scheduled experimental protocols. , 50 (n = 7), 75 (n = 6), and 100 mg/kg (n = 5). These are the same doses we used in our previous study to determine the impact on sleep of rats of 5-HTP injected at dark onset (20) .
Experimental manipulations were randomly scheduled with an interval of at least three days between injections and no animal received more than one vehicle and three doses of 5-HTP. All injections were given 15 min prior to light onset. Recordings began at light onset and continued for 23 hours. The two lowest doses of 5-HTP used in this study (25 and 50 mg/kg) induced a transient hypothermic response (Table 1) Figure 1 ). REM sleep was reduced during the first four postinjection hours after each of the doses of 5-HTP used in this study ( Table 1 ). The reduction in REM sleep persisted for 12-h postinjection after the 100 mg/kg dose of 5-HTP (Table 1 , Figure 1 ).
During the subsequent dark period (post-injection hours 13 -23) wakefulness was reduced after the 50 -100 mg/kg doses of 5-HTP (Table 1, Figure 1 ). NREM sleep increased during this time after 50 and 100 mg/kg 5-HTP, and there was a tendency for increased NREM sleep after the 75 mg/kg dose that did not quite achieve statistical significance (Table 1) . There was an increase in REM sleep after administration of 50 mg/kg 5-HTP, and a tendency for increased REM sleep after 75 mg/kg 5-HTP (Table 1) Additional experiments are necessary to fully elucidate potential interactions between the serotonergic system, CRH and/or the HPA axis as they pertain to the modulation of sleep-wake behavior and temperature regulation. 
